IFNA2 and melanoma: In this context, Yi and colleagues demonstrated that SSG inhibitor synergizes with IFN-α to overcome IFN-α resistance in different human cancer cell lines and extinguishes IFN-α-refractory WM9 human melanoma tumors in nude mice without displaying adverse effects [154].